Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1305 |
| Name of the vaccine | BK1301 |
| Microbe | Bacteria |
| Disease name | Tetanus (Lock Jaw) |
| Name of bacteria | Clostridium tetani |
| Type of vaccine | Combination |
| Nucleic acid content | DNA |
| Age | 11 to 12 years |
| Description of the vaccine | DTaP vaccine. |
| Name of the manufacturer | Mitsubishi Tanabe Pharma Corporation |
| Name of the manufacturing country | Japan |
| Year of manufacture | 2014 |
| Clinical Phase status | Clinical - Phase 3 |
| Bacterial strain | Gram-positive bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Single dose of 0.5 mL. |
| Mechanism of action | Anti-pertussis toxoid. |
| Route of administration | Subcutaneous |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For pertussis and diphtheria. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT02118961 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |